Home › Myelofibrosis
Pag-aaral pangklinika para sa Myelofibrosis na nagre-recruit sa U.S.
56 pag-aaral para sa Myelofibrosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX19 pag-aaral
- New York City, NY18 pag-aaral
- Boston, MA12 pag-aaral
- Durham, NC12 pag-aaral
- Columbus, OH11 pag-aaral
- Seattle, WA11 pag-aaral
- Miami, FL10 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Tampa, FL9 pag-aaral
- Cleveland, OH9 pag-aaral
- Atlanta, GA9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Nashville, TN9 pag-aaral
- St. Louis, MO8 pag-aaral
- Ann Arbor, MI8 pag-aaral
- Mountain View, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Baltimore, MD7 pag-aaral
- Birmingham, AL7 pag-aaral
- Philadelphia, PA6 pag-aaral
- Winston-Salem, NC6 pag-aaral
- Los Angeles, CA6 pag-aaral
- Irvine, CA5 pag-aaral
- Portland, OR5 pag-aaral
- Kansas City, MO5 pag-aaral
- Dallas, TX5 pag-aaral
- Cincinnati, OH5 pag-aaral
- Edison, NJ4 pag-aaral
- Jacksonville, FL4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Minneapolis, MN4 pag-aaral
- Charlotte, NC4 pag-aaral
- Denver, CO4 pag-aaral
- New Haven, CT4 pag-aaral
- Washington, DC4 pag-aaral
- Gilbert, AZ3 pag-aaral
- Aurora, CO3 pag-aaral
- Coral Springs, FL3 pag-aaral
- Sacramento, CA3 pag-aaral
- Orange, CA3 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona7 pag-aaral
- California21 pag-aaral
- Colorado6 pag-aaral
- Connecticut5 pag-aaral
- Florida14 pag-aaral
- Georgia9 pag-aaral
- Illinois7 pag-aaral
- Kansas6 pag-aaral
- Maryland9 pag-aaral
- Massachusetts13 pag-aaral
- Michigan10 pag-aaral
- Minnesota7 pag-aaral
- Missouri8 pag-aaral
- New Jersey6 pag-aaral
- New York21 pag-aaral
- North Carolina17 pag-aaral
- Ohio17 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania8 pag-aaral
- South Carolina4 pag-aaral
- Tennessee9 pag-aaral
- Texas20 pag-aaral
- Utah10 pag-aaral
- Virginia5 pag-aaral
- Washington11 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07469891A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07357727A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07623161Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07521046A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06661915Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04176198A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06343805Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04282187High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06345495Pacritinib Effectiveness in Real-world Settings
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07774455A Telehealth Advance Care Planning Intervention
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05875805Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07228624TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07302776A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07008118Quantitative MRI for Myelofibrosis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT01973881A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07020533A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06773195Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07250646Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT04370301Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT07128381Allo HSCT Using RIC and PTCy for Hematological Diseases
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT05805605Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.